141 related articles for article (PubMed ID: 10144889)
1. Department of Justice challenging big insurers' "Most Favored Nation" clauses.
Stepovich M
Health Care Law Newsl; 1995 Sep; 10(9):3-4. PubMed ID: 10144889
[TBL] [Abstract][Full Text] [Related]
2. Potential anticompetitive effects of most favored nation contract clauses in managed care and health insurance contracts.
Dennis AJ
Ann Health Law; 1995; (4):71-85. PubMed ID: 10143197
[No Abstract] [Full Text] [Related]
3. A competitive analysis of most favored nations clauses in contracts between health care providers and insurers.
Celnicker A
Spec Law Dig Health Care (Mon); 1991 Dec; (154):7-36. PubMed ID: 10115476
[TBL] [Abstract][Full Text] [Related]
4. Most-favored-nation clauses and monopsonistic power: an unhealthy mix?
Stenger SE
Am J Law Med; 1989; 15(1):111-28. PubMed ID: 2764011
[TBL] [Abstract][Full Text] [Related]
5. Competitors share contracts.
Lovern E
Mod Healthc; 2001 Jan; 31(3):4-5, 10. PubMed ID: 11418946
[No Abstract] [Full Text] [Related]
6. Evaluating antitrust risk in joint provider negotiations with payors.
Leonard EJ
Med Staff Couns; 1992; 6(1):41-7. PubMed ID: 10115450
[TBL] [Abstract][Full Text] [Related]
7. Providers weigh Varney exit. Focus on antitrust laws made 'companies take notice'.
Carlson J
Mod Healthc; 2011 Jul; 41(28):12-3. PubMed ID: 21853589
[No Abstract] [Full Text] [Related]
8. Santa Fe provider network goes unchallenged by the DOJ.
Busey RC
Healthc Financ Manage; 1997 May; 51(5):86-7. PubMed ID: 10167301
[TBL] [Abstract][Full Text] [Related]
9. New York court refuses to block merger of Long Island hospitals.
Padden M
Healthc Financ Manage; 1998 Mar; 52(3):34-7. PubMed ID: 10177397
[TBL] [Abstract][Full Text] [Related]
10. Do State Bans of Most-Favored-Nation Contract Clauses Restrain Price Growth? Evidence From Hospital Prices.
Arnold DR; Gudiksen KL; King JS; Fulton BD; Scheffler RM
Milbank Q; 2022 Jun; 100(2):589-615. PubMed ID: 35537077
[TBL] [Abstract][Full Text] [Related]
11. Oligopsony, health insurance and antitrust.
Hilsenrath PE; Destigter M
Med Group Manage J; 1996; 43(2):52-8. PubMed ID: 10155946
[No Abstract] [Full Text] [Related]
12. Assembled Products: The Key to More Effective Competition And Antitrust Oversight in Health Care.
Sage WM
Cornell Law Rev; 2016; 101(3):609-700. PubMed ID: 27062731
[TBL] [Abstract][Full Text] [Related]
13. Exclusive contracts between hospitals and physicians: the antitrust issues.
Frech HE; Danger KL
Health Econ; 1998 Mar; 7(2):175-8. PubMed ID: 9565175
[TBL] [Abstract][Full Text] [Related]
14. Are you violating antitrust laws?
Saylor LJ
Mich Hosp; 1992; 28(1):29-33. PubMed ID: 10116190
[TBL] [Abstract][Full Text] [Related]
15. The legal framework for effective competition.
Berenson RA; Hastings DA; Kopit WG
Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
[TBL] [Abstract][Full Text] [Related]
16. Strength in numbers or antitrust trouble?
Bianculli JL
Contemp Longterm Care; 1997 May; 20(5):60-1. PubMed ID: 10167546
[No Abstract] [Full Text] [Related]
17. Unbridled managed care: when consumers experience antitrust welfare loss from exclusionary contracts between HMO insurers and health care providers.
Ruskin A
Health Matrix Clevel; 1996; 6(2):391-469. PubMed ID: 10178393
[No Abstract] [Full Text] [Related]
18. Ore. upstart takes on rival.
Taylor M
Mod Healthc; 2002 Feb; 32(6):18-9, 21. PubMed ID: 11892528
[No Abstract] [Full Text] [Related]
19. Legal considerations for periodontists in dealing with managed care organizations.
Bierig JR
J Periodontol; 1998 Feb; 69(2):254-60. PubMed ID: 9526925
[TBL] [Abstract][Full Text] [Related]
20. How MFN clauses used in the health care industry unreasonably restrain trade under the Sherman Act.
Wright BA
J Law Health; 2003-2004; 18(1):29-55. PubMed ID: 16521890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
